scholarly article | Q13442814 |
P2093 | author name string | Kai Wang | |
Yongsheng Yu | |||
Xiaoping Wan | |||
Shuangdi Li | |||
P2860 | cites work | The neural cell recognition molecule neurofascin interacts with syntenin-1 but not with syntenin-2, both of which reveal self-associating activity | Q24290724 |
Characterization of syntenin, a syndecan-binding PDZ protein, as a component of cell adhesion sites and microfilaments | Q24290826 | ||
Syntenin is overexpressed and promotes cell migration in metastatic human breast and gastric cancer cell lines | Q24298538 | ||
A novel eIF5A complex functions as a regulator of p53 and p53-dependent apoptosis | Q24304245 | ||
The postsynaptic density 95/disc-large/zona occludens protein syntenin directly interacts with frizzled 7 and supports noncanonical Wnt signaling | Q24311477 | ||
Syntenin, a PDZ protein that binds syndecan cytoplasmic domains | Q24311619 | ||
Syndecan-syntenin-ALIX regulates the biogenesis of exosomes | Q24337195 | ||
Extensions of PSD-95/discs large/ZO-1 (PDZ) domains influence lipid binding and membrane targeting of syntenin-1 | Q24337436 | ||
PDZ tandem of human syntenin: crystal structure and functional properties | Q27640904 | ||
Structure of PICK1 and other PDZ domains obtained with the help of self-binding C-terminal extensions | Q27644225 | ||
Crystal structure of a PDZ domain | Q27733300 | ||
PDZ domains: structural modules for protein complex assembly | Q28210680 | ||
The role of synaptic GTPase-activating protein in neuronal development and synaptic plasticity | Q28211165 | ||
Interleukin-10 and related cytokines and receptors | Q28251518 | ||
Targeted Covalent Inhibition of Grb2-Sos1 Interaction through Proximity-Induced Conjugation in Breast Cancer Cells | Q30008796 | ||
Expression analysis and genomic characterization of human melanoma differentiation associated gene-5, mda-5: a novel type I interferon-responsive apoptosis-inducing gene. | Q30336430 | ||
The binding of the PDZ tandem of syntenin to target proteins. | Q30439757 | ||
Melanoma differentiation associated gene-9, mda-9, is a human gamma interferon responsive gene | Q32086811 | ||
Elevated expression of syntenin in breast cancer is correlated with lymph node metastasis and poor patient survival | Q33739518 | ||
Differentiation therapy in acute myelogenous leukemia (non-APL). | Q33864593 | ||
Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of nuclear factor-kappaB. | Q33884626 | ||
Syntenin-syndecan binding requires syndecan-synteny and the co-operation of both PDZ domains of syntenin | Q33898645 | ||
In vitro selection of unnatural cyclic peptide libraries via mRNA display | Q34077317 | ||
Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression | Q34135637 | ||
mda-9/syntenin: recent insights into a novel cell signaling and metastasis-associated gene | Q34363845 | ||
Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression | Q34369804 | ||
Syndecan binding protein (SDCBP) is overexpressed in estrogen receptor negative breast cancers, and is a potential promoter for tumor proliferation | Q34638020 | ||
MDA-9/Syntenin regulates differentiation and angiogenesis programs in head and neck squamous cell carcinoma | Q34781101 | ||
MDA-9/syntenin is essential for factor VIIa-induced signaling, migration, and metastasis in melanoma cells | Q35055504 | ||
Rigidified clicked dimeric ligands for studying the dynamics of the PDZ1-2 supramodule of PSD-95. | Q35434851 | ||
MDA-9/syntenin and IGFBP-2 promote angiogenesis in human melanoma | Q36545071 | ||
MDA-9/Syntenin-Slug transcriptional complex promote epithelial-mesenchymal transition and invasion/metastasis in lung adenocarcinoma. | Q36729428 | ||
Syntenin, a syndecan adaptor and an Arf6 phosphatidylinositol 4,5-bisphosphate effector, is essential for epiboly and gastrulation cell movements in zebrafish | Q36851334 | ||
mda-9/Syntenin promotes metastasis in human melanoma cells by activating c-Src | Q36949152 | ||
Selected approaches for rational drug design and high throughput screening to identify anti-cancer molecules | Q37149641 | ||
mda-9/Syntenin: more than just a simple adapter protein when it comes to cancer metastasis | Q37152452 | ||
MDA-9/syntenin is a key regulator of glioma pathogenesis | Q37409706 | ||
Novel role of MDA-9/syntenin in regulating urothelial cell proliferation by modulating EGFR signaling. | Q37412627 | ||
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer | Q37533025 | ||
Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin | Q37589930 | ||
Raf kinase inhibitor RKIP inhibits MDA-9/syntenin-mediated metastasis in melanoma | Q37611006 | ||
Syntenin increases the invasiveness of small cell lung cancer cells by activating p38, AKT, focal adhesion kinase and SP1. | Q37679452 | ||
Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells | Q37688017 | ||
MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer | Q37696985 | ||
MDA-9/syntenin: a positive gatekeeper of melanoma metastasis. | Q37971509 | ||
In vivo modeling of malignant glioma: the road to effective therapy | Q38216989 | ||
SAR by interligand nuclear overhauser effects (ILOEs) based discovery of acylsulfonamide compounds active against Bcl-x(L) and Mcl-1. | Q38281136 | ||
Syntenin and syndecan in the biogenesis of exosomes | Q38511561 | ||
PDZ-Reactive Peptide Activates Ephrin-B Reverse Signaling and Inhibits Neuronal Chemotaxis. | Q38822961 | ||
Mda-9/syntenin promotes human brain glioma migration through focal adhesion kinase (FAK)-JNK and FAK-AKT signaling. | Q39287553 | ||
Endocytosis of the neuronal glycine transporter GLYT2: role of membrane rafts and protein kinase C-dependent ubiquitination. | Q39475468 | ||
The tandem PDZ domains of syntenin promote cell invasion | Q40142496 | ||
JAK kinases control IL-5 receptor ubiquitination, degradation, and internalization. | Q40182524 | ||
Differentiation, differentiation/gene therapy and cancer | Q41334613 | ||
Melanoma-Derived iPCCs Show Differential Tumorigenicity and Therapy Response | Q42038580 | ||
Activation of the integrin effector kinase focal adhesion kinase in cancer cells is regulated by crosstalk between protein kinase Calpha and the PDZ adapter protein mda-9/Syntenin | Q42467088 | ||
The ins and outs of syntenin, a multifunctional intracellular adaptor protein | Q46055534 | ||
Syntenin is involved in the developmental regulation of neuronal membrane architecture | Q46410469 | ||
CRISPR/Cas9 knockouts reveal genetic interaction between strain-transcendent erythrocyte determinants of Plasmodium falciparum invasion | Q48014614 | ||
The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells | Q48073787 | ||
Myc suppresses tumor invasion and cell migration by inhibiting JNK signaling | Q48371923 | ||
The MDA-9/Syntenin/IGF-1R/STAT3 axis directs prostate cancer invasion. | Q52430984 | ||
Syntenin-targeted peptide blocker inhibits progression of cancer cells. | Q54977384 | ||
MDA-9/Syntenin regulates protective autophagy in anoikis-resistant glioma stem cells. | Q55457100 | ||
Nanotechnology for treatment of glioblastoma multiforme | Q58695662 | ||
Regulation of protective autophagy in anoikis-resistant glioma stem cells by SDCBP/MDA-9/Syntenin | Q62746678 | ||
mda-9/Syntenin: a positive regulator of melanoma metastasis | Q64378235 | ||
Lung Cancer Therapy Targeting Histone Methylation: Opportunities and Challenges | Q90013973 | ||
Biophysics of Tumor Microenvironment and Cancer Metastasis - A Mini Review | Q91051911 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | PDZ domain | Q24721050 |
P304 | page(s) | 136-141 | |
P577 | publication date | 2019-01-01 | |
P1433 | published in | Computational and Structural Biotechnology Journal | Q19865804 |
P1476 | title | A PDZ Protein MDA-9/Syntenin: As a Target for Cancer Therapy | |
P478 | volume | 17 |
Q89728843 | MDA-9/Syntenin (SDCBP): Novel gene and therapeutic target for cancer metastasis |
Q97419455 | Mimicking the Endometrial Cancer Tumor Microenvironment to Reprogram Tumor-Associated Macrophages in Disintegrable Supramolecular Gelatin Hydrogel |
Q92905820 | Syntenin: PDZ Protein Regulating Signaling Pathways and Cellular Functions |
Q92880008 | Targeted Therapy of Uveal Melanoma: Recent Failures and New Perspectives |